Engineered antibodies enhance complement-mediated immune clearance against drug-resistant bacterial infections
By
Wilhelm Schwaeble
Crisp on the outside, thoughtful on the inside. A keeper.
Summary
Researchers engineered monoclonal antibodies (mAbs) that bypass the initial steps of the classical complement activation pathway, enhancing their ability to clear bacterial infections. This strategy addresses the challenge that mAbs targeting bacteria must do more than neutralize pathogens—they need to trigger complement activation and engage Fc receptors for immune clearance. The approach shows promise against antimicrobial-resistant pathogens, offering a potential therapeutic avenue for the growing crisis of drug-resistant bacterial infections.
Key quotes
· 5 pulledMonoclonal antibodies (mAbs) have demonstrated promise in treating infectious diseases, including bacterial infections.
Unlike much smaller viruses, mAbs targeting bacteria need to do more than simply neutralize the pathogen.
These mAbs need to trigger the activation of complement and engage Fc receptors to promote the immune clearance of pathogens.
Ali et al. engineered a strategy to shortcut the initiation steps of the classical complement activation pathway and therefore increase the ability of pathogen-targeting mAbs to clear infections.
The expanding global crisis of bacterial infections caused by antimicrobial-resistant pathogens has resulted in an urgent need for therapeutics.
You might also wanna read
Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial
Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic
rockefeller.edu·9mo ago
Company Develops Magnetically Controlled Antibody for Targeted Drug Delivery
A company called Nonfiction Labs has developed a remote-controlled antibody that can be turned on and off using a magnet. This breakthrough
bsky.app·4mo ago
Novel Blood-Brain Barrier Modulation Strategy Shows Promise for Alzheimer's Treatment Through Enhanced Amyloid-β Clearance
This scientific research presents a novel therapeutic approach for Alzheimer's disease that targets the blood-brain barrier (BBB) to enhance
nature.com·8mo ago
New Protein Therapy Offers Potential Antidote for Carbon Monoxide Poisoning
Researchers from the University of Maryland School of Medicine have developed a new molecule that shows promise as an effective antidote for
medschool.umaryland.edu·10mo ago
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove
blog.google·8mo ago
Emerging Evidence Challenges Immunity Debt Theory, Suggests SARS-CoV-2 Alters Immune Systems
Scientists are challenging the 'immunity debt' theory that explained post-pandemic infection surges, instead proposing that SARS-CoV-2 may b
bmj.com·9mo ago